Overview
MLSS market data
Price History
MLSS price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.07 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.20 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -51.3% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.22 – $0.68 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $48.6M · P/B 7.63 · P/S 5.46.
Company News
Milestone Scientific shares are trading lower after the company reported Q2 financial results and issued Q3 sales guidance below analyst estimates.Benzinga · Aug 14, 2026, 4:53 PM
Conference Call: Milestone Scientific Affirms FY2026 Sales Guidance of $9.800M-$10.200M vs $9.910M EstBenzinga · Aug 14, 2026, 2:40 PM
Conference Call: Milestone Scientific Sees Q3 Sales $2.300M-$2.500M vs $2.510M EstBenzinga · Aug 14, 2026, 2:40 PM
Transcript: Milestone Scientific Q2 2026 Earnings Conference CallBenzinga · Aug 14, 2026, 1:10 PM
Milestone Scientific Q2 EPS $(0.01), Inline, Sales $2.841M Beat $2.700M EstimateBenzinga · Aug 13, 2026, 8:28 PM
Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference CallGlobenewswire Inc · Aug 6, 2026, 1:16 PM
Milestone Scientific Announces Distribution Agreement With Red One Medical To Market CompuFlo Epidural System To VA, Department Of Defense And Other Federal Healthcare SystemsBenzinga · Aug 4, 2026, 12:33 PM
8-K filing — MILESTONE SCIENTIFIC INC. (MLSS)SEC EDGAR · Jul 31, 2026, 3:50 PM
Milestone Scientific Expects Q2 Revenue Of ~$2.8M, Up 21% YoY; H1 Revenue Of ~$5M, Up 9% YoYBenzinga · Jul 1, 2026, 12:40 PM
Milestone Scientific Notes Growing Clinical Adoption And Physician Acceptance Of Its CompuFlo Epidural System After Research PublicationBenzinga · May 27, 2026, 12:54 PM